Hydrops Fetalis: Clinical Trials

1 trial for Hydrops Fetalis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow Hydrops Fetalis: new trials by email Literature Review of Hydrops Fetalis trials Research Report on Hydrops Fetalis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM)
in utero hematopoietic stem cell transplantation - Alpha Thalassemia Major, Hemoglobinopathy; With Thalassemia
Phase 1TerminatedUniversity of California, San Francisco62017-10-052025-01-27

Narrower conditions

Hemoglobinopathies (1)  ·  Thalassemia (1)  ·  alpha-Thalassemia (1)  ·  beta-Thalassemia (1)

Broader conditions

Anemia (1)  ·  Anemia, Hemolytic (1)  ·  Anemia, Hemolytic, Congenital (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Edema (1)  ·  Erythroblastosis, Fetal (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Fetal Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pregnancy Complications (1)  ·  Signs and Symptoms (1)

Sponsors

University of California, San Francisco (1)

Countries

United States (1)

Top investigators

Tippi Mackenzie, MD (1)

Results publications

PMID 27862048, PMID 39891377, PMID 41984996